This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Ascendis Pharma A/S
Drug Names(s): TransCon Hydrogel Pramipexole
Description: TransCon Hydrogel Pramipexole is a subcutaneous reformulation of Mirapex, a dopamine agonist. It aims to improve efficacy and compliance by replacing multiple oral dosages with a once-weekly subcutaneous injection using a small 30G needle.
Additional information available to subscribers only: